CCL2 as a potential therapeutic target for clear cell renal cell carcinoma.
Arakaki R, Yamasaki T, Kanno T, Shibasaki N, Sakamoto H, Utsunomiya N, Sumiyoshi T, Shibuya S, Tsuruyama T, Nakamura E, Ogawa O, Kamba T.
Arakaki R, et al. Among authors: sakamoto h.
Cancer Med. 2016 Oct;5(10):2920-2933. doi: 10.1002/cam4.886. Epub 2016 Sep 26.
Cancer Med. 2016.
PMID: 27666332
Free PMC article.